[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409. CHINESE DIABETES SOCIETY.Chinese guidelines for the prevention and treatment of type 2 diabetes (2020 edition)[J]. Chinese Journal of Diabetes,2021,13(4):315-409.(in Chinese) [2] 关羽晴,解汝娟.糖尿病肾病及其心血管并发症研究的进展[J].心血管康复医学杂志,2022,31(2):214-218. GUAN Y Q,XIE R J.Research progress of diabetic nephropathy and its cardiovascular[J].Chinese Journal of Cardiovascular Rehabilitation Medicine,2022,31(2):214-218.(in Chinese) [3] YANG C,WANG H,ZHAO X,et al.CKD in China:Evolving spectrum and public health implications[J].American Journal of Kidney Diseases,2020,76(2):258-264. [4] ZHANG L,ZHAO M H,ZUO L,et al.China kidney disease network (CK-NET)2016 annual data report[J].Kidney International Supplements,2020,10(2):e97-185. [5] BLOOM C A,RAND J S.Diabetes and the kidney in human and veterinary medicine[J].The Veterinary Clinics of North America.Small Animal Practice,2013,43(2):351-365. [6] REIDY K,KANG H M,HOSTETTER T,et al.Molecular mechanisms of diabetic kidney disease[J].The Journal of Clinical Investigation,2014,124(6):2333-2340. [7] WILLIAMS J G,HESS R S.Concurrent disorders of cats with diabetes mellitus and arterial systolic hypertension[J].Journal of Feline Medicine and Surgery,2023,25(7):1098612X231187691. [8] SPARKES A H,CANNON M,CHURCH D,et al.ISFM consensus guidelines on the practical management of diabetes mellitus in cats[J].Journal of Feline Medicine and Surgery,2015,17(3):235-250. [9] PETERSON M E,EIRMANN L.Dietary management of feline endocrine disease[J].The Veterinary Clinics of North America.Small Animal Practice,2014,44(4):775-788. [10] NAVANEETHAN S D,ZOUNGAS S,CARAMORI M L,et al.Diabetes management in chronic kidney disease:Synopsis of the 2020 KDIGO clinical practice guideline[J].Annals of Internal Medicine,2021,174(3):385-394. [11] 刘东伟,李征永,刘章锁.糖尿病肾病治疗:立足基点热点、突破靶点焦点[J].中华医学杂志,2021,101(10):683-686. LIU D W,LI Z Y,LIU Z S.Treatment of diabetic kidney disease:Research development,current hotspots and future directions[J]. National Medical Journal of China,2021,101(10):683-686.(in Chinese) [12] TSIKAS D.Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples:Analytical and biological challenges[J].Analytical Biochemistry,2017,524:13-30. [13] HOU Y,TAN E,SHI H,et al.Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney[J].Cellular and Molecular Life Sciences,2024,81(1):23. [14] KRIZ W,LEMLEY K V.A potential role for mechanical forces in the detachment of podocytes and the progression of CKD[J].Journal of the American Society of Nephrology,2015,26(2):258-269. [15] GHORBANI A.Mechanisms of antidiabetic effects of flavonoid rutin[J].Biomedicine & Pharmacotherapy,2017,96:305-312. [16] WANG X,MA Y,XU Q,et al.Flavonoids and saponins:What have we got or missed?[J].Phytomedicine,2023,109:154580. [17] DIAS M C,PINTO D C G A,SILVA A M S.Plant flavonoids:Chemical characteristics and biological activity[J].Molecules (Basel,Switzerland),2021,26(17):5377. [18] FENG Q,YANG Y,QIAO Y,et al.Quercetin ameliorates diabetic kidney injury by inhibiting ferroptosis via activating Nrf2/Ho-1 signaling pathway[J].The American Journal of Chinese Medicine,2023,51(4):997-1018. [19] ALSHEHRI A S.Kaempferol attenuates diabetic nephropathy in streptozotocin-induced diabetic rats by a hypoglycaemic effect and concomitant activation of the Nrf-2/Ho-1/antioxidants axis[J].Archives of Physiology and Biochemistry,2023,129(4):984-997. [20] ELSAMAN T,AHMAD I,ELTAYIB E M,et al.Flavonostilbenes natural hybrids from Rhamnoneuron balansae as potential antitumors targeting ALDH1A1:Molecular docking,ADMET,MM-GBSA calculations and molecular dynamics studies[J].Journal of Biomolecular Structure & Dynamics,2024,42(6):3249-3266. [21] 覃迅云,罗金裕,高志刚.中国瑶药学[M].南宁:广西民族出版社,2002. QIN X Y,LUO J Y,GAO Z G.Yao Medicine in China[M].Nanning:National Publishing House,2002.(in Chinese) [22] 李 丽,罗泽萍,周焕第,等.地菍乙酸乙酯提取部位对糖尿病小鼠血糖、血脂及抗氧化作用的影响[J].中国老年学杂志,2015,35(12):3250-3252. LI L,LUO Z P,ZHOU H D,et al.Effects of ethyl acetate extract from Melastoma dodecandrum Lour.on blood glucose,blood lipid and antioxidation in diabetic mice[J].Chinese Journal of Gerontology,2015,35(12):3250-3252.(in Chinese) [23] 李 丽,罗泽萍,周焕第,等.地菍正丁醇萃取物对链脲佐菌素致糖尿病模型小鼠的影响[J].医药导报,2014,33(2):173-176. LI L,LUO Z P,ZHOU H D,et al.Effect of Melastoma dodecandrum Lour.N-butanol extract on streptozotocin-induced diabetic model mice[J].Herald of Medicine,2014,33(2):173-176.(in Chinese) [24] 李 丽,罗泽萍,杨秀芬,等.地菍醇提物对糖尿病模型小鼠血糖的影响[J].中国老年学杂志,2014,34(11):3091-3093. LI L,LUO Z P,YANG X F,et al.Effects of ethanol extract of Melastoma dodecandrum Lour.on blood glucose and glucose tolerance in normal mice[J].Chinese Journal of Gerontology,2014,34(11):3091-3093.(in Chinese) [25] 李 丽,罗泽萍,周焕第,等.瑶药地菍不同提取部位的降血糖活性研究[J].中成药,2014,36(5):1065-1068. LI L,LUO Z P,ZHOU H D,et al.Study on hypoglycemic activity of different extracts of Yao medicine Melastoma dodecandrum Lour.[J] Chinese Traditional Patent Medicine,2014,36(5):1065-1068.(in Chinese) [26] 翁竞玉,周敬凯,陈静梅,等.地菍黄酮对糖尿病小鼠糖脂代谢及氧化应激的影响[J].中国老年学杂志,2020,40(9):1950-1953. WENG J Y,ZHOU J K,CHEN J M.et al.Effects of Melastoma dodecandrum Lour.flavone on glucolipid metabolism and oxidative stress in diabetic mice[J].Chinese Journal of Gerontology,2020,40(9):1950-1953.(in Chinese) [27] WENG J,ZHOU J,LIANG L.et al.UHPLC/QTOF-MS-based metabolomics reveal the effect of Melastoma dodecandrum extract in type 2 diabetic rats[J].Pharmaceutical Biology,2019,57(1):807-815. [28] 莫烨云,朱 盼,唐雨菲,等.地菍总黄酮抗2型糖尿病作用机制的网络药理学研究及实验验证[J].现代药物与临床,2024,39(1):23-33. MO Y Y,ZHU P,TANG Y F,et al.Mechanism of Melastoma dodecandrum flavonoids in treatment of type 2 diabetes mellitus on network pharmacology and validation[J].Drugs & Clinic,2024,39(1):23-33.(in Chinese) [29] 周敬凯.地菍总黄酮对高脂饮食诱导肥胖大鼠的干预作用及其机制研究[D].南宁:广西中医药大学,2021. ZHOU J K.Intervention from total flavonoids of Melastoma dodecandrum Lour.on obesity rats induced by high fat diet and its mechanism[D].Nanning:Guangxi University of Chinese Medicine,2021.(in Chinese) [30] 唐雨菲,周敬凯,莫烨云,等.地菍总黄酮对高脂饮食诱导非酒精性脂肪肝大鼠脂代谢的影响[J].中国畜牧兽医,2023,50(8):3438-3447. TANG Y F,ZHOU J K,MO Y Y,et al.Effect of total flavonoids from Melastoma dodecandrum Lour.on nonalcoholic fatty liver induced by high fat diet in rats[J].China Animal Husbandry & Veterinary Medicine,2023,50(8):3438-3447.(in Chinese) [31] MALOBERTI P M,DUARTE A B,ORLANDO U D,et al.Functional interaction between acyl-CoA synthetase 4,lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells[J].PLoS One,2010,5(11):e15540. [32] SALMAN Z K,REFAAT R,SELIMA E,et al.The combined effect of metformin and L-cysteine on inflammation,oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats[J].European Journal of Pharmacology,2013,714(1-3):448-455. [33] SUSZTAK K,RAFF A C,SCHIFFER M,et al.Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy[J].Diabetes,2006,55(1):225-233. [34] 张宗玮,丁国华.足细胞细胞骨架改变与肾小球疾病的研究进展[J].中华肾脏病杂志,2022,38(5):447-452. ZHANG Z W,DING G H.Advances in researches on podocyte cytoskeleton alterations and glomerular diseases[J].Chinese Journal of Nephrology,2022,38(5):447-452.(in Chinese) [35] MULUKALA S K,NISHAD R,KOLLIGUNDLA L P,et al. In silico structural characterization of podocin and assessment of nephrotic syndrome-associated podocin mutants[J].IUBMB Life,2016,68(7):578-588. [36] FORBES J M,COUGHLAN M T,COOPER M E.Oxidative stress as a major culprit in kidney disease in diabetes[J].Diabetes,2008,57(6):1446-1454. [37] 宋开永,熊维建,田 璐,等.脂毒性致糖尿病肾病肾小球滤过屏障损伤机制研究进展[J].中国医药导报,2023,20(34):36-39. SONG K Y,XIONG W J,TIAN L,et al.Research progress on the mechanism of damage of diabetic kidney disease glomerular filtration barrier caused by lipotoxicity[J].China Medical Herald,2023,20(34):36-39.(in Chinese) [38] 王 祥.糖尿病心肌病的工程化心肌组织模型建立及铁死亡的致病机制研究[D].长春:吉林大学,2021. WANG X.Establishment of an engineered cardiac tissue model of diabetic cardiomyopathy and study on the pathogenesis of ferroptosis[J].Changchun:Jilin University,2021.(in Chinese) [39] YE Z,LIU W,ZHUO Q,et al.Ferroptosis:Final destination for cancer?[J].Cell Proliferation,2020,53(3):e12761. [40] RINALDI A,LAZARETH H,POINDESSOUS V,et al.Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury[J].JCI Insight,2022,7(18):e161783. [41] ZHANG W,LU J,WANG Y,et al.Canagliflozin attenuates lipotoxicity in cardiomyocytes by inhibiting inflammation and ferroptosis through activating AMPK pathway[J].International Journal of Molecular Sciences,2023,24(1):858. [42] FANG X,SONG J,CHEN Y,et al.lncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR-16-5p/ACSL4 axis to alleviate diabetic nephropathy[J].Journal of Diabetes Investigation,2023,14(9):1056-1069. [43] GUAN Y,DAVIS L,BREYER M D,et al.Cyclooxygenase-2 contributes to diabetic nephropathy through glomerular EP4 receptor[J].Prostaglandins & Other Lipid Mediators,2022,159:106621. |